Ulf Müeller-Ladner

3.9k total citations · 1 hit paper
28 papers, 1.3k citations indexed

About

Ulf Müeller-Ladner is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Ulf Müeller-Ladner has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 8 papers in Molecular Biology and 8 papers in Rheumatology. Recurrent topics in Ulf Müeller-Ladner's work include Systemic Sclerosis and Related Diseases (9 papers), COVID-19 Clinical Research Studies (5 papers) and Inflammasome and immune disorders (5 papers). Ulf Müeller-Ladner is often cited by papers focused on Systemic Sclerosis and Related Diseases (9 papers), COVID-19 Clinical Research Studies (5 papers) and Inflammasome and immune disorders (5 papers). Ulf Müeller-Ladner collaborates with scholars based in Germany, United Kingdom and France. Ulf Müeller-Ladner's co-authors include Veit Krenn, Thomas Häupl, Lars Morawietz, B Müller, Raimund W. Kinne, Hendrik Schulze‐Koops, Iain B. McInnes, Robert Landewé, Désirée van der Heijde and Elena Neumann and has published in prestigious journals such as The Lancet, Annals of the New York Academy of Sciences and CHEST Journal.

In The Last Decade

Ulf Müeller-Ladner

25 papers receiving 1.3k citations

Hit Papers

Synovitis score: discrimination between chronic low‐grade... 2006 2026 2012 2019 2006 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Synovitis score: discrimination between chronic low‐grade and high‐grade synovitis
    2006 577 citations Veit Krenn, Lars Morawietz et al. Histopathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulf Müeller-Ladner Germany 13 627 215 215 203 201 28 1.3k
Pravin Hissaria Australia 20 305 0.5× 379 1.8× 335 1.6× 243 1.2× 161 0.8× 92 1.6k
Alessandra Soriano Italy 24 447 0.7× 343 1.6× 212 1.0× 308 1.5× 208 1.0× 68 1.5k
Sandra Gofinet Pasoto Brazil 21 635 1.0× 545 2.5× 151 0.7× 94 0.5× 159 0.8× 82 1.3k
Alexios Iliopoulos Greece 16 521 0.8× 422 2.0× 131 0.6× 103 0.5× 110 0.5× 47 964
Yang‐Che Wu Taiwan 25 686 1.1× 100 0.5× 219 1.0× 166 0.8× 203 1.0× 77 1.9k
Maryam Piram France 22 294 0.5× 334 1.6× 191 0.9× 398 2.0× 485 2.4× 60 1.4k
Varun Dhir India 19 608 1.0× 232 1.1× 194 0.9× 93 0.5× 178 0.9× 115 1.2k
Tanja Kveder Slovenia 23 1.1k 1.8× 375 1.7× 155 0.7× 148 0.7× 236 1.2× 63 1.7k
Giuseppe Maria Milano Italy 22 405 0.6× 199 0.9× 229 1.1× 349 1.7× 250 1.2× 100 1.6k
Mo Yin Mok Hong Kong 26 981 1.6× 931 4.3× 333 1.5× 197 1.0× 241 1.2× 54 1.9k

Countries citing papers authored by Ulf Müeller-Ladner

Since Specialization
Citations

This map shows the geographic impact of Ulf Müeller-Ladner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Müeller-Ladner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Müeller-Ladner more than expected).

Fields of papers citing papers by Ulf Müeller-Ladner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Müeller-Ladner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Müeller-Ladner. The network helps show where Ulf Müeller-Ladner may publish in the future.

Co-authorship network of co-authors of Ulf Müeller-Ladner

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Müeller-Ladner. A scholar is included among the top collaborators of Ulf Müeller-Ladner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Müeller-Ladner. Ulf Müeller-Ladner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hasseli, Rebecca, Ulf Müeller-Ladner, Bimba F. Hoyer, et al.. (2021). Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. RMD Open. 7(1). e001464–e001464. 66 indexed citations
3.
Regierer, Anne C., Rebecca Hasseli, Martin Schäfer, et al.. (2021). TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD. RMD Open. 7(3). e001896–e001896. 17 indexed citations
4.
Klemm, Philipp, et al.. (2021). Widespread soft tissue calcification in systemic sclerosis, polymyositis, and polyarthritis. The Lancet. 397(10272). 409–409. 1 indexed citations
5.
Furer, Victoria, Christien Rondaan, Nancy Agmon‐Levin, et al.. (2021). Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases. RMD Open. 7(1). e001594–e001594. 44 indexed citations
6.
Landewé, Robert, Pedro Machado, Féline P B Kroon, et al.. (2020). EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Annals of the Rheumatic Diseases. 79(7). 851–858. 153 indexed citations
7.
Talarico, Rosaria, Stefano Bombardieri, Gerd R Burmester, et al.. (2020). Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey. RMD Open. 6(2). e001344–e001344. 8 indexed citations
8.
Roodenrijs, Nadia M T, Maria J. H. de Hair, Marlies C. van der Goes, et al.. (2018). Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey. Annals of the Rheumatic Diseases. 77(12). 1705–1709. 90 indexed citations
9.
Ndosi, Mwidimi, Begonya Alcacer‐Pitarch, Yannick Allanore, et al.. (2018). Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study. Annals of the Rheumatic Diseases. 77(7). 1032–1038. 13 indexed citations
10.
Adler, Sabine, Dörte Huscher, Elise Siegert, et al.. (2018). Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group. Arthritis Research & Therapy. 20(1). 17–17. 67 indexed citations
11.
Neumann, Elena, Maria Schwarz, Rebecca Hasseli, et al.. (2018). Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts. Annals of the Rheumatic Diseases. 77(11). 1619–1626. 17 indexed citations
12.
Visvanathan, Sudha, Meera Ramanujam, Corinna Schoelch, et al.. (2016). FRI0231 Treatment with BI 655064 (Antagonistic Anti-CD40 Antibody) Modulates Biomarkers Associated with Rheumatoid Arthritis (RA). Annals of the Rheumatic Diseases. 75. 517–517. 1 indexed citations
13.
Mihai, Carina, Robert Landewé, Désirée van der Heijde, et al.. (2015). Digital ulcers predict a worse disease course in patients with systemic sclerosis. Annals of the Rheumatic Diseases. 75(4). 681–686. 95 indexed citations
14.
Adler, Scott, Dörte Huscher, Yannick Allanore, et al.. (2014). USE OF IMMUNOSUPPRESSANTS IN SSC PATIENTS WITH INTERSTITIAL LUNG DISEASE - RESULTS OF THE DESSCIPHER PROJECT OF THE EUSTAR GROUP.
15.
Brocher, Jan, Patricia Janicki, Elisabeth Seebach, et al.. (2013). Inferior ectopic bone formation of mesenchymal stromal cells from adipose tissue compared to bone marrow: Rescue by chondrogenic pre-induction. Stem Cell Research. 11(3). 1393–1406. 43 indexed citations
16.
Ruiz‐Heiland, Gisela, Yi Zhao, Anja Derer, et al.. (2013). Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis. Annals of the Rheumatic Diseases. 73(4). 771–779. 28 indexed citations
17.
Lambova, Sevdalina Nikolova & Ulf Müeller-Ladner. (2012). AB0838 New aspects regarding microvascular abnormalities in systemic sclerosis. Annals of the Rheumatic Diseases. 71. 686–686. 2 indexed citations
18.
19.
Schedel, J, et al.. (2010). Cerebral lesions in patients with connective tissue diseases and systemic vasculitides: are there specific patterns?. Annals of the New York Academy of Sciences. 1193(1). 167–175. 5 indexed citations
20.
Krenn, Veit, Lars Morawietz, Raimund W. Kinne, et al.. (2006). Synovitis score: discrimination between chronic low‐grade and high‐grade synovitis. Histopathology. 49(4). 358–364. 577 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pravin Hissaria Breakdown of academic impact, for papers by Alessandra Soriano Breakdown of academic impact, for papers by Sandra Gofinet Pasoto Breakdown of academic impact, for papers by Alexios Iliopoulos Breakdown of academic impact, for papers by Yang‐Che Wu Breakdown of academic impact, for papers by Maryam Piram Breakdown of academic impact, for papers by Varun Dhir Breakdown of academic impact, for papers by Tanja Kveder Breakdown of academic impact, for papers by Giuseppe Maria Milano Breakdown of academic impact, for papers by Mo Yin Mok
Rankless by CCL
2026